167 related articles for article (PubMed ID: 37815735)
21. Prevalence of bacterial bloodstream infections and association between neutropenia and 30-day mortality among oncology inpatients at a university hospital in Saudi Arabia.
Binkhamis K; Aldakhil I; Alhawas A; Alsaleh A; Albaroudi A; Almuhanna B; Makkawi M; Alzahrani M
Ann Saudi Med; 2023; 43(3):172-178. PubMed ID: 37270682
[TBL] [Abstract][Full Text] [Related]
22. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Gudiol C; Albasanz-Puig A; Laporte-Amargós J; Pallarès N; Mussetti A; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Paz Morales H; Brunel AS; García E; Isler B; Kern WV; Morales I; Maestro-de la Calle G; Montero M; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J;
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015035
[TBL] [Abstract][Full Text] [Related]
23. Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes.
Sood P; Seth T; Kapil A; Sharma V; Dayama A; Sharma S; Kumar S; Singh AK; Mishra P; Mahapatra M
J Indian Med Assoc; 2012 Jul; 110(7):439-44. PubMed ID: 23520666
[TBL] [Abstract][Full Text] [Related]
24. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases.
Tofas P; Skiada A; Angelopoulou M; Sipsas N; Pavlopoulou I; Tsaousi S; Pagoni M; Kotsopoulou M; Perlorentzou S; Antoniadou A; Pirounaki M; Skoutelis A; Daikos GL
Int J Antimicrob Agents; 2016 Apr; 47(4):335-9. PubMed ID: 27005460
[TBL] [Abstract][Full Text] [Related]
25. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study.
Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C;
Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202
[TBL] [Abstract][Full Text] [Related]
26. High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations.
Chumbita M; Puerta-Alcalde P; Yáñez L; Angeles Cuesta M; Chinea A; Español-Morales I; Fernandez-Abellán P; Gudiol C; González-Sierra P; Rojas R; Sánchez-Pina JM; Vadillo IS; Sánchez M; Varela R; Vázquez L; Guerreiro M; Monzo P; Lopera C; Aiello TF; Peyrony O; Soriano A; Garcia-Vidal C
Microbiol Spectr; 2023 Aug; 11(4):e0067423. PubMed ID: 37367629
[TBL] [Abstract][Full Text] [Related]
27. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
Righi E; Peri AM; Harris PN; Wailan AM; Liborio M; Lane SW; Paterson DL
J Antimicrob Chemother; 2017 Mar; 72(3):668-677. PubMed ID: 27999023
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and microbiological characteristics of bloodstream infections in adult neutropenic patients].
Finello M; Suasnabar DF; García MJ; Díaz MV; Richetta L; Toranzo A; Hernández D; Cometto MA; Vázquez SM; Caeiro JP; Sierra J; Saad EJ
Rev Argent Microbiol; 2021; 53(3):183-193. PubMed ID: 33388181
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of pathogens and clinical characteristics of bloodstream infection in neutropenic children with hematological malignancies from 2014 to 2018].
Zhu GQ; Xu CH; Lin QS; Wang XX; Wang LL; Zhao NN; Feng SZ; Chen YM
Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):655-660. PubMed ID: 32942819
[No Abstract] [Full Text] [Related]
30. Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review.
Pezzani MD; Arieti F; Rajendran NB; Barana B; Cappelli E; De Rui ME; Galia L; Hassoun-Kheir N; Argante L; Schmidt J; Rodriguez-Bano J; Harbarth S; de Kraker M; Gladstone BP; Tacconelli E
Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S4-S13. PubMed ID: 38007387
[TBL] [Abstract][Full Text] [Related]
31. Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS).
Weisser M; Theilacker C; Tschudin Sutter S; Babikir R; Bertz H; Götting T; Dettenkofer M; Kern WV; Widmer AF;
Clin Microbiol Infect; 2017 Nov; 23(11):854-859. PubMed ID: 28366613
[TBL] [Abstract][Full Text] [Related]
32. Bloodstream infections and antibiotic resistance patterns: a six-year surveillance study from southern Italy.
Foglia F; Della Rocca MT; Melardo C; Nastri BM; Manfredini M; Montella F; De Filippis A; Finamore E; Galdiero M
Pathog Glob Health; 2023 Jun; 117(4):381-391. PubMed ID: 36190133
[TBL] [Abstract][Full Text] [Related]
33. [Epidemiological analysis of pathogens causing bloodstream infections in department of hematology in Guangdong Province].
Zhuo CY; Guo YY; Liu NJ; Liu BM; Xiao SN; Zhang Y; Guo XC; Li DN; Tan SY; He NH; Mai Y; Guan J; Zhuo C
Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):996-1001. PubMed ID: 33445846
[No Abstract] [Full Text] [Related]
34. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
35. Bloodstream infections in oncology patients at Red Cross War Memorial Children's Hospital, Cape Town, from 2012 to 2014.
Mvalo T; Eley B; Bamford C; Stanley C; Chagomerana M; Hendricks M; Van Eyssen A; Davidson A
Int J Infect Dis; 2018 Dec; 77():40-47. PubMed ID: 30244075
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility.
Shargian L; Paul M; Nachshon T; Ayada G; Nesher L; Raanani P; Ben-Zvi H; Henig O; Yahav D
Eur J Clin Microbiol Infect Dis; 2023 Feb; 42(2):177-182. PubMed ID: 36502498
[TBL] [Abstract][Full Text] [Related]
37. Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapy.
Sathya Kumar AM; George MM; Bhanuprasad K; John GM; Korula A; Abraham A; Mathews V; Kulkarni UP; Shankar C; Premkumar PS; Chacko B; Subramani K; Varghese GM; Balaji V; George B
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):12. PubMed ID: 36793051
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Kamimura T; Shimono N; Akashi K
PLoS One; 2013; 8(1):e54190. PubMed ID: 23372683
[TBL] [Abstract][Full Text] [Related]
39. Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.
Chaftari AM; Hachem R; Jordan M; Garoge K; Al Hamal Z; El Zakhem A; Viola GM; Granwehr B; Mulanovich V; Gagel A; Reitzel R; Yousif A; Jiang Y; Raad I
Antimicrob Agents Chemother; 2016 Jan; 60(1):239-44. PubMed ID: 26482312
[TBL] [Abstract][Full Text] [Related]
40. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.
Rangaraj G; Granwehr BP; Jiang Y; Hachem R; Raad I
Cancer; 2010 Feb; 116(4):967-73. PubMed ID: 20052728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
